Interestingly, a recent report investigating novel therapeutic targets in idiopathic pulmonary fibrosis (IPF) identified Leukemia Inhibitory Factor receptor (LIFR) as an “autocrine master amplifier” of multiple upstream activators of lung fibroblasts (32). Here, LIFR is linked to pulmonary fibrosis.